Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Inge Johnsen

Showing results (1-10 of 83) with videos related to

Pageof 9
Sort By:
Cancers|February 24, 2024
Recent Advances in Neuroblastoma ResearchJohn Inge Johnsen, Per Kogner
World Journal of Experimental Medicine|February 21, 2015
Cytomegalovirus in human brain tumors: Role in pathogenesis and potential treatment optionsCecilia Söderberg-Nauclér, John Inge Johnsen
Oncoimmunology|August 31, 2012
Cytomegalovirus infection in brain tumors: A potential new target for therapy?Cecilia Söderberg-Nauclér, John Inge Johnsen
Molecular & Cellular Oncology|June 17, 2016
Wingless/β-catenin signaling as a modulator of chemoresistance in cancerJohn Inge Johnsen, Malin Wickström, Ninib Baryawno
Experimental Cell Research|March 10, 2010
Omega-3 fatty acids in cancer, the protectors of good and the killers of evil?Helena Gleissman, John Inge Johnsen, Per Kogner
Frontiers in Molecular Neuroscience|February 15, 2019
Neuroblastoma-A Neural Crest Derived Embryonal MalignancyJohn Inge Johnsen, Cecilia Dyberg, Malin Wickström
Current Oncology Reports|April 1, 2022
Neuroblastoma Heterogeneity, Plasticity, and Emerging TherapiesKristina Ihrmark Lundberg, Diana Treis, John Inge Johnsen
Advances in Cancer Research|April 20, 2010
MYC in oncogenesis and as a target for cancer therapiesAmi Albihn, John Inge Johnsen, Marie Arsenian Henriksson
Oncotarget|January 17, 2012
Is human cytomegalovirus a target in cancer therapy?John Inge Johnsen, Ninib Baryawno, Cecilia Söderberg-Nauclér
Pharmacological Research|February 22, 2018
Molecular mechanisms and therapeutic targets in neuroblastomaJohn Inge Johnsen, Cecilia Dyberg, Susanne Fransson, et al.
Pageof 9

Showing results (1-10 of 83) with videos related to

Sort By:
Pageof 9
Cancers|February 24, 2024
Recent Advances in Neuroblastoma ResearchJohn Inge Johnsen, Per Kogner
World Journal of Experimental Medicine|February 21, 2015
Cytomegalovirus in human brain tumors: Role in pathogenesis and potential treatment optionsCecilia Söderberg-Nauclér, John Inge Johnsen
Oncoimmunology|August 31, 2012
Cytomegalovirus infection in brain tumors: A potential new target for therapy?Cecilia Söderberg-Nauclér, John Inge Johnsen
Molecular & Cellular Oncology|June 17, 2016
Wingless/β-catenin signaling as a modulator of chemoresistance in cancerJohn Inge Johnsen, Malin Wickström, Ninib Baryawno
Experimental Cell Research|March 10, 2010
Omega-3 fatty acids in cancer, the protectors of good and the killers of evil?Helena Gleissman, John Inge Johnsen, Per Kogner
Frontiers in Molecular Neuroscience|February 15, 2019
Neuroblastoma-A Neural Crest Derived Embryonal MalignancyJohn Inge Johnsen, Cecilia Dyberg, Malin Wickström
Current Oncology Reports|April 1, 2022
Neuroblastoma Heterogeneity, Plasticity, and Emerging TherapiesKristina Ihrmark Lundberg, Diana Treis, John Inge Johnsen
Advances in Cancer Research|April 20, 2010
MYC in oncogenesis and as a target for cancer therapiesAmi Albihn, John Inge Johnsen, Marie Arsenian Henriksson
Oncotarget|January 17, 2012
Is human cytomegalovirus a target in cancer therapy?John Inge Johnsen, Ninib Baryawno, Cecilia Söderberg-Nauclér
Pharmacological Research|February 22, 2018
Molecular mechanisms and therapeutic targets in neuroblastomaJohn Inge Johnsen, Cecilia Dyberg, Susanne Fransson, et al.
Pageof 9